• Identify typical signs of normal (reassuring) and abnormal (nonreassuring) fetal heart rate (FHR) patterns.
• Compare FHR monitoring performed by intermittent auscultation with external and internal electronic methods.
• Explain the baseline FHR and evaluate periodic changes.
• Describe nursing measures that can be used to maintain FHR patterns within normal limits.
• Differentiate among the nursing interventions used for managing specific FHR patterns, including tachycardia and bradycardia, absent or minimal variability, and late and variable decelerations.
• Review the documentation of the monitoring process necessary during labor.
The ability to assess the fetus by auscultation of the fetal heart was initially described more than 300 years ago. With the advent of the fetoscope and stethoscope after the turn of the twentieth century the listener could hear clearly enough to count the FHR. When electronic FHR monitoring made its debut for clinical use in the early 1970s, the anticipation was that its use would result in fewer cases of cerebral palsy and be more sensitive than stethoscopic auscultation in predicting and preventing fetal compromise (Garite, 2007). Consequently, the use of electronic fetal monitoring rapidly expanded. However, the rate of cerebral palsy has not declined since that time and is not likely to improve, because more preterm infants are surviving and because these infants have an increased risk for congenitally acquired neurologic damage (Gilbert, 2011). Moreover, in 2008 the cesarean birth rate in the United States reached an all-time high of 32.3% (Hamilton, Martin, & Ventura, 2010).
Still, electronic fetal monitoring (EFM) is a useful tool for visualizing FHR patterns on a monitor screen or printed tracing. It continues to be the primary mode of intrapartum fetal assessment in the United States and is the most commonly performed obstetric procedure in that country (American College of Obstetricians and Gynecologists [ACOG], 2009; Tucker, Miller, & Miller, 2009). Pregnant women should be informed about the equipment and procedures used and the risks, benefits, and limitations of intermittent auscultation and EFM. This chapter discusses the basis for intrapartum fetal monitoring, the types of monitoring, and nursing assessment and management of abnormal fetal status.
Because labor is a period of physiologic stress for the fetus, frequent monitoring of fetal status is part of the nursing care during labor. The fetal oxygen supply must be maintained during labor to prevent fetal compromise and to promote newborn health after birth. The fetal oxygen supply can decrease in a number of ways:
• Reduction of blood flow through the maternal vessels as a result of maternal hypertension (chronic hypertension, preeclampsia, or gestational hypertension), hypotension (caused by supine maternal position, hemorrhage, or epidural analgesia or anesthesia), or hypovolemia (caused by hemorrhage)
• Reduction of the oxygen content in the maternal blood as a result of hemorrhage or severe anemia
• Alterations in fetal circulation, occurring with compression of the umbilical cord (transient, during uterine contractions [UCs], or prolonged, resulting from cord prolapse), placental separation or complete abruption, or head compression (head compression causes increased intracranial pressure and vagal nerve stimulation with an accompanying decrease in the FHR)
• Reduction in blood flow to the intervillous space in the placenta secondary to uterine hypertonus (generally caused by excessive exogenous oxytocin) or secondary to deterioration of the placental vasculature associated with maternal disorders such as hypertension or diabetes mellitus
Fetal well-being during labor can be measured by the response of the FHR to UCs. A group of fetal monitoring experts recommended that FHR tracings demonstrating certain reassuring characteristics be described as normal (category I) (Box 18-1).
Table 18-1 describes normal uterine activity (UA) during labor.
TABLE 18-1
NORMAL UTERINE ACTIVITY DURING LABOR
CHARACTERISTIC | DESCRIPTION |
Frequency | Contraction frequency overall generally ranges from two to five per 10 minutes during labor, with lower frequencies seen in the first stage of labor and higher frequencies (up to five contractions in 10 minutes) seen during the second stage of labor. |
Duration | Contraction duration remains fairly stable throughout the first and second stages, ranging from 45-80 seconds, not generally exceeding 90 seconds. |
Intensity (peak less resting tone) | Intensity of uterine contractions generally range from 25-50 mm Hg in the first stage of labor and may rise to over 80 mm Hg in second stage. Contractions palpated as “mild” would likely peak at less than 50 mm Hg if measured internally, whereas contractions palpated as “moderate” or greater would likely peak at 50 mm Hg or greater if measured internally. |
Resting tone | Average resting tone during labor is 10 mm Hg; if using palpation, should palpate as “soft” (i.e., easily indented, no palpable resistance). |
Montevideo units (MVUs) | Ranges from 100-250 MVUs in the first stage, may rise to 300-400 in the second stage. Contraction intensities of 40 mm Hg or more and MVUs of 80-120 are generally sufficient to initiate spontaneous labor. MVUs are used only with internal monitoring of contractions. |
Sources: Tucker, S., Miller, L., & Miller, D. (2009). Mosby’s pocket guide to fetal monitoring: A multidisciplinary approach (6th ed.). St. Louis: Mosby; Macones, G., Hankins, G, Spong, C., Hauth, J., & Moore, T. (2008). The 2008 National Institute of Child Health and Human Development Workshop Report on Electronic Fetal Monitoring: Update on definitions, interpretation, and research guidelines. Journal of Obstetric, Gynecologic and Neonatal Nursing, 37(5), 510-515.
The goals of intrapartum FHR monitoring are to identify and differentiate the normal (reassuring) patterns from the abnormal (nonreassuring) patterns, which can be indicative of fetal compromise. Although the 2008 National Institute of Child Health and Human Development workshop (Macones, Hankins, Spong, Hauth, & Moore, 2008) and ACOG (2009) both recommend use of the terms normal and abnormal to describe FHR tracings, the terms reassuring and nonreassuring are still frequently used clinically.
Abnormal FHR patterns are those associated with fetal hypoxemia, which is a deficiency of oxygen in the arterial blood. If uncorrected, hypoxemia can deteriorate to severe fetal hypoxia, which is an inadequate supply of oxygen at the cellular level. See Box 18-1 for examples of abnormal (category III) FHR tracings.
The ideal method of fetal assessment during labor continues to be debated. Research findings support the use of both intermittent auscultation (IA) of the FHR and electronic FHR monitoring (Gilbert, 2011). Although IA is a high-touch, low-technology method of assessing fetal status during labor that places fewer restrictions on maternal activity, more than 85% of laboring women in the United States are monitored electronically for at least part of their labor (ACOG, 2009; Tucker et al., 2009). The continued use of EFM in place of IA is thought to be due to concerns about liability and the increased nurse-client ratio required with IA. Because all surveillance methods including EFM have limitations, some feel the evidence supports a return to the use of IA for low risk laboring women (ACOG; Tucker et al.).
Intermittent auscultation involves listening to fetal heart sounds at periodic intervals to assess the FHR. IA of the fetal heart can be performed with a Pinard stethoscope, Doppler ultrasound (Fig.18-1, A), an ultrasound stethoscope (see Fig. 18-1, B), or a DeLee-Hillis fetoscope (see Fig. 18-1, C). The fetoscope is applied to the listener’s forehead because bone conduction amplifies the fetal heart sounds for counting. Doppler ultrasound and ultrasound stethoscopes transmit ultra high-frequency sound waves, reflecting movement of the fetal heart, and convert these sounds into an electronic signal that can be counted. Box 18-2 describes how to perform IA.
FIG. 18-1 A, Ultrasound fetoscope. B, Ultrasound stethoscope. C, DeLee-Hillis fetoscope. (Courtesy Michael S. Clement, MD, Mesa, AZ.)
IA is easy to use, inexpensive, and less invasive than EFM. It is often more comfortable for the woman and gives her more freedom of movement. Other care measures, such as ambulation and the use of baths or showers, are easier to carry out when IA is used. However, IA may be difficult to perform in women who are obese. Because IA is intermittent, significant events may occur during a time when the FHR is not being auscultated. Also IA does not provide a permanent documented visual record of the FHR and cannot be used to assess visual patterns of the FHR variability or periodic changes (Albers, 2007; Tucker et al., 2009). By using IA the nurse can assess the baseline FHR, rhythm, and increases and decreases from baseline.
The American College of Nurse-Midwives reviewed references from the United States, Great Britain, and Canada regarding the recommended frequency of IA in low risk women and found consistent recommendations for every 15 minutes in the active phase of the first stage of labor and every 5 minutes in the second stage of labor (Tucker et al., 2009). ACOG (2009) concurs that these time frames are acceptable for IA in low risk women. The Association of Women’s Health, Obstetric and Neonatal Nurses (AWHONN) recommends different IA frequencies: every hour in the latent phase of first stage labor, every 30 minutes in the active phase of first stage labor, and every 15 minutes in the second stage of labor (AWHONN, 2009). However, the optimal frequency for IA in low risk women during labor has not been determined (Nageotte & Gilstrap, 2009).
Every effort should be made to use the method of fetal assessment the woman desires, if possible. However, auscultation of the FHR in accordance with the frequency guidelines suggested earlier may be difficult in today’s busy labor and birth units. When used as the primary method of fetal assessment, auscultation requires a one-to-one nurse-to-client staffing ratio. If acuity and census change so that auscultation standards are no longer met, the nurse must inform the physician or nurse-midwife that continuous EFM will be used until staffing can be arranged to meet the standards.
The woman can become anxious if the examiner cannot readily count the fetal heartbeats. It often takes time for the inexperienced listener to locate the heartbeat and find the area of maximal intensity. To allay the mother’s concerns, she can be told that the nurse is “finding the spot where the sounds are loudest.” If it takes considerable time to locate the fetal heartbeats, the examiner can reassure the mother by offering her an opportunity to listen to them, too. If the examiner cannot locate the fetal heartbeat, assistance should be requested. In some cases ultrasound can be used to help locate the fetal heartbeat. Seeing the FHR on the ultrasound screen will be reassuring to the mother if there was initial difficulty in locating the best area for auscultation.
When using IA, uterine activity is assessed by palpation. The examiner should keep his or her fingertips placed over the fundus before, during, and after contractions. The contraction intensity is usually described as mild, moderate, or strong. The contraction duration is measured in seconds, from the beginning to the end of the contraction. The frequency of contractions is measured in minutes, from the beginning of one contraction to the beginning of the next contraction. The examiner should keep his or her hand on the fundus after the contraction is over to evaluate uterine resting tone or relaxation between contractions. Resting tone between contractions is usually described as soft or relaxed (AWHONN, 2009).
Accurate and complete documentation of fetal status and uterine activity is especially important when IA and palpation are being used because no paper tracing record or computer storage of these assessments is provided as is the case with continuous EFM. Labor flow records or computer charting systems that prompt notations of all assessments are useful for ensuring such comprehensive documentation.
The purpose of electronic FHR monitoring is the ongoing assessment of fetal oxygenation. FHR tracings are analyzed for characteristic patterns that suggest fetal hypoxic events and metabolic acidosis during labor. When hypoxia or metabolic acidosis is suspected in labor, interventions to resolve the problem can be implemented in a timely manner before permanent damage or death occurs (Garite, 2007). The two modes of electronic fetal monitoring include the external mode, which uses external transducers placed on the maternal abdomen to assess FHR and uterine activity, and the internal mode, which uses a spiral electrode applied to the fetal presenting part to assess the FHR and an intrauterine pressure catheter (IUPC) to assess UA and uterine resting tone. The differences between the external and internal modes of EFM are summarized in Table 18-2.
Separate transducers are used to monitor the FHR and UCs (Fig. 18-2). The ultrasound transducer works by reflecting high-frequency sound waves off a moving interface: in this case, the fetal heart and valves. It is sometimes difficult to reproduce a continuous and precise record of the FHR because of artifact introduced by fetal and maternal movement. Maternal obesity, occiput posterior position of the fetus, and anterior attachment of the placenta can cause weak or absent signals (AWHONN, 2009). The FHR is printed on specially formatted monitor paper. The standard paper speed used in the United States is 3 cm/min. Once the area of maximal intensity of the FHR has been located, conductive gel is applied to the surface of the ultrasound transducer, and the transducer is then positioned over this area and held securely in place using an elastic belt.
FIG. 18-2 A, External noninvasive fetal monitoring with tocotransducer and ultrasound transducer. B, Ultrasound transducer is placed below umbilicus, over the area where fetal heart rate is best heard, and tocotransducer is placed on uterine fundus. (B, Courtesy Marjorie Pyle, RNC, Lifecircle, Costa Mesa, CA.)
The tocotransducer (tocodynamometer) measures UA transabdominally. The device is placed over the fundus above the umbilicus and held securely in place using an elastic belt (see Fig. 18-2, B). UCs or fetal movements depress a pressure-sensitive surface on the side next to the abdomen. The tocotransducer can measure and record the frequency and approximate duration of UCs but not their intensity. This method is especially valuable for measuring UA during the first stage of labor in women with intact membranes or for antepartum testing. If the woman is obese, the tocotransducer may be unable to detect the exact frequency and duration of UA.
Because the tocotransducer of most electronic fetal monitors is designed for assessing UA in the term pregnancy, it may not be sensitive enough to detect preterm UA. When monitoring the woman in preterm labor, remember that the fundus may be located below the level of the umbilicus. The nurse may need to rely on the woman to indicate when UA is occurring and to use palpation as an additional way of assessing contraction frequency and validating the monitor tracing.
The external transducers are easily applied by the nurse, but often must be repositioned as the woman or fetus changes position. The woman is asked to assume a semi-Fowler’s or lateral position. Use of external transducers confines the woman to bed or chair. Portable telemetry monitors allow observation of the FHR and UC patterns by means of centrally located electronic display stations. These portable units permit the woman to walk around during electronic monitoring.
The technique of continuous internal FHR or UA monitoring provides a more accurate appraisal of fetal well-being during labor than external monitoring because it is not interrupted by fetal or maternal movement or affected by maternal size (Fig. 18-3). For this type of monitoring, the membranes must be ruptured, the cervix sufficiently dilated (at least 2 to 3 cm), and the presenting part low enough to allow placement of the spiral electrode or intrauterine pressure catheter or both. Internal and external modes of monitoring may be combined (i.e., internal FHR with external UA or external FHR with internal UA) without difficulty.
FIG. 18-3 Diagrammatic representation of internal invasive fetal monitoring with intrauterine pressure catheter and spiral electrode in place (membranes ruptured and cervix dilated).
Internal monitoring of the FHR is accomplished by attaching a small spiral electrode to the presenting part. For UA to be monitored internally an IUPC is introduced into the uterine cavity. The catheter has a pressure-sensitive tip that measures changes in intrauterine pressure. As the catheter is compressed during a contraction, pressure is placed on the pressure transducer. This pressure is then converted into a pressure reading in millimeters of mercury (mm Hg). The IUPC can objectively measure the frequency, duration, and intensity of UC, as well as uterine resting tone.
Because it can precisely measure the intensity of individual UCs, the IUPC can be used to evaluate the adequacy of UA for achieving progress in labor. Montevideo units (MVUs) are calculated by subtracting the baseline uterine pressure from the peak contraction pressure for each contraction that occurs in a 10 minute window, and then adding together the pressures generated by each contraction that occurs during that period of time. Spontaneous labor usually begins when MVUs are between 80 and 120. Uterine activity during normal labor rarely exceeds 250 MVUs (see Table 18-1) (Cunningham, Leveno, Bloom, Hauth, Rouse, & Spong, 2010; Tucker et al., 2009).
The FHR and UA are displayed on the monitor paper or computer screen, with the FHR in the upper section and UA in the lower section. Figure 18-4 contrasts the internal and external modes of electronic monitoring. Note that each small square on the monitor paper or screen represents 10 seconds; each larger box of six squares equals 1 minute (when paper is moving through the monitor at the rate of 3 cm/min).
FIG. 18-4 Display of fetal heart rate and uterine activity on monitor paper. A, External mode with ultrasound and tocotransducer as signal source. B, Internal mode with spiral electrode and intrauterine catheter as signal source. Frequency of contractions is measured from the beginning of one contraction to the beginning of the next. (From Tucker, S., Miller, L., & Miller, D. [2009]. Mosby’s pocket guide to fetal monitoring: A multidisciplinary approach [6th ed.]. St. Louis: Mosby.)
Characteristic FHR patterns are associated with fetal and maternal physiologic processes and have been identified for many years. Because EFM was introduced into clinical practice before consensus was reached in regard to standardized terminology, however, variations in the description and interpretation of common fetal heart rate patterns were often great. In 1997 the National Institute of Child Health and Human Development (NICHD) published a proposed nomenclature system for EFM interpretation with standardized definitions for FHR monitoring. The NICHD recommendations were not widely incorporated into clinical practice, however, until they were endorsed by ACOG in 2005. Shortly thereafter, use of the NICHD standard terminology was also endorsed by AWHONN and the American College of Nurse-Midwives (ACNM) (Tucker et al., 2009). All three organizations cited concerns regarding client safety and the need for improved communication among caregivers as reasons for using standard EFM definitions in clinical practice.
In April 2008 the NICHD, ACOG, and the Society for Maternal-Fetal Medicine partnered to sponsor another workshop to revisit the FHR definitions recommended by the NICHD in 1997. The 1997 FHR definitions were reaffirmed at this workshop. In addition, new definitions related to UA were recommended, as well as a three-tier system of FHR pattern interpretation and categorization (Macones et al., 2008).
The intrinsic rhythmicity of the fetal heart, the central nervous system (CNS), and the fetal autonomic nervous system control the FHR. An increase in sympathetic response results in acceleration of the FHR, whereas an increase in parasympathetic response produces a slowing of the FHR. Usually a balanced increase of sympathetic and parasympathetic response occurs during contractions, with no observable change in the baseline FHR.
The baseline fetal heart rate is the average rate during a 10-minute segment that excludes periodic or episodic changes, periods of marked variability, and segments of the baseline that differ by more than 25 beats/min. There must be at least 2 minutes of interpretable baseline data in a 10-minute segment of tracing in order to determine the baseline FHR (Macones et al, 2008). After 10 minutes of tracing is observed the approximate mean rate is rounded to the closest 5-beats/min interval (AWHONN, 2009). For example, if the FHR rate varies between 130 and 140 beats/min over a 10-minute period, the baseline is recorded as 135 beats/min. The normal range at term is 110 to 160 beats/min. In the preterm fetus the baseline rate is slightly higher.
Variability of the FHR can be described as irregular waves or fluctuations in the baseline FHR of two cycles per minute or greater (Macones et al., 2008). It is a characteristic of the baseline FHR and does not include accelerations or decelerations of the FHR. Variability is quantified in beats per minute and is measured from the peak to the trough of a single cycle. Four possible categories of variability have been identified: absent, minimal, moderate, and marked (Fig. 18-5). In the past, variability was described as either long term or short term (beat to beat). The NICHD definitions do not distinguish between long- and short-term variability, however, because in actual practice they are visually determined as a unit (NICHD, 1997).
FIG. 18-5 Fetal heart rate variability. A, Absent variability; amplitude range undetectable. B, Minimal variability; amplitude range detectable up to and including 5 beats/min. C, Moderate variability; amplitude range 6 to 25 beats/min. D, Marked variability; amplitude range >25 beats/min. (From Tucker, S., Miller, L., & Miller, D. [2009]. Mosby’s pocket guide to fetal monitoring: A multidisciplinary approach [6th ed.]. St. Louis: Mosby.)
Depending on other characteristics of the FHR tracing, absent or minimal variability is classified as either abnormal or indeterminate (Macones et al., 2008) (see Fig. 18-5, A and B). It can result from fetal hypoxemia and metabolic acidemia. Other possible causes of absent or minimal variability include congenital anomalies and preexisting neurologic injury. CNS depressant medications, including analgesics, narcotics (meperidine [Demerol]), barbiturates (secobarbital [Seconal] and pentobarbital [Nembutal]), tranquilizers (diazepam [Valium]), ataractics (promethazine [Phenergan]), and general anesthetics are other possible causes of minimal variability. In addition, minimal variability can occur with tachycardia, extreme prematurity, or when the fetus is temporarily in a sleep state (Tucker et al., 2009). These sleep states do not usually last longer than 30 minutes.
Moderate variability, however, is considered normal (see Fig. 18-5, C). Its presence is highly predictive of a normal fetal acid-base balance (absence of fetal metabolic acidemia). Moderate variability indicates that FHR regulation is not significantly affected by fetal sleep cycles, tachycardia, prematurity, congenital anomalies, preexisting neurologic injury, or CNS depressant medications (Macones et al., 2008; Tucker et al., 2009).
The significance of marked variability (see Fig. 18-5, D) is unclear (Macones et al., 2008). A sinusoidal pattern—a regular smooth, undulating wavelike pattern—is not included in the definition of FHR variability. This uncommon pattern classically occurs with severe fetal anemia (Fig. 18-6) (Tucker et al., 2009).
Tachycardia is a baseline FHR greater than 160 beats/min for 10 minutes or longer (Fig. 18-7). It can be considered an early sign of fetal hypoxemia, especially when associated with late decelerations and minimal or absent variability. Fetal tachycardia can result from maternal or fetal infection, such as prolonged rupture of membranes with amnionitis; from maternal hyperthyroidism or fetal anemia; or in response to medications such as atropine, hydroxyzine (Vistaril), terbutaline (Brethine), or illicit drugs such as cocaine or methamphetamines. Table 18-3 lists causes, clinical significance, and nursing interventions for tachycardia.
Bradycardia is a baseline FHR less than 110 beats/min for 10 minutes or longer (Fig. 18-8). True bradycardia occurs rarely and is not specifically related to fetal oxygenation. True bradycardia must be distinguished from a prolonged deceleration because the causes and management of these two conditions are very different. Bradycardia is often caused by some type of fetal cardiac problem such as structural defects involving the pacemakers or conduction system or fetal heart failure. Other causes of bradycardia include viral infections (e.g., cytomegalovirus), maternal hypoglycemia, and maternal hypothermia. The clinical significance of the bradycardia depends on the underlying cause and accompanying FHR patterns, including variability and the presence of accelerations or decelerations (Tucker et al., 2009). (See Table 18-3 for a list of causes, clinical significance, and nursing interventions for bradycardia.)
Changes in FHR from the baseline are categorized as periodic or episodic. Periodic changes are those that occur with UCs. Episodic changes are those that are not associated with UCs. These patterns include both accelerations and decelerations (Macones et al., 2008).
Acceleration of the FHR is defined as a visually apparent abrupt (onset to peak less than 30 seconds) increase in FHR above the baseline rate (Fig. 18-9). The peak is at least 15 beats/min above the baseline, and the acceleration lasts 15 seconds or more, with the return to baseline less than 2 minutes from the beginning of the acceleration. Before 32 weeks of gestation the definition of an acceleration is a peak of 10 beats/min or more above the baseline and a duration of at least 10 seconds. Acceleration of the FHR for more than 10 minutes is considered a change in baseline rate (Tucker et al., 2009).
FIG. 18-9 Fetal accelerations. (From Tucker, S., Miller, L., & Miller, D. [2009]. Mosby’s pocket guide to fetal monitoring: A multidisciplinary approach [6th ed.]. St. Louis: Mosby.)
Accelerations can be periodic or episodic. They may occur in association with fetal movement or spontaneously. If accelerations do not occur spontaneously, they can be elicited by fetal scalp stimulation or vibroacoustic stimulation. Similar to moderate variability, accelerations are considered an indication of fetal well-being. Their presence is highly predictive of a normal fetal acid-base balance (absence of fetal metabolic acidemia) (Tucker et al., 2009). Box 18-3 lists causes, clinical significance, and nursing interventions for accelerations.
A deceleration (caused by dominance of a parasympathetic response) may be benign or abnormal (nonreassuring). FHR decelerations are categorized as early, late, variable, or prolonged. They are described by their visual relation to the onset and end of a contraction and by their shape.
Early Decelerations: Early deceleration of the FHR is a visually apparent gradual (onset to lowest point ≥30 seconds) decrease in and return to baseline FHR associated with UCs. They are thought to be caused by transient fetal head compression and are considered a normal and benign finding (Macones et al., 2008; Tucker et al., 2009). Generally the onset, nadir, and recovery of the deceleration correspond to the beginning, peak, and end of the contraction (Fig. 18-10). For this reason, early decelerations are sometimes called the “mirror image” of a contraction.
FIG. 18-10 Early decelerations. (From Tucker, S. [2004]. Pocket guide to fetal monitoring and assessment [5th ed.]. St. Louis: Mosby.)
Early decelerations may occur during uterine contractions, during vaginal examinations, as a result of fundal pressure, and during placement of the internal mode of fetal monitoring. When present, they usually occur during the first stage of labor when the cervix is dilated 4 to 7 cm. Early decelerations are also sometimes seen during the second stage when the woman is pushing.
Because early decelerations are considered to be benign, interventions are not necessary. The value of identifying early decelerations is so that they can be distinguished from late or variable decelerations, which can be abnormal (nonreassuring) and for which interventions are appropriate. Box 18-4 lists causes, clinical significance, and nursing interventions for early decelerations.
Late Decelerations: Late deceleration of the FHR is a visually apparent gradual decrease in and return to baseline FHR associated with UCs (Macones et al., 2008). The deceleration begins after the contraction has started, and the lowest point of the deceleration occurs after the peak of the contraction. The deceleration usually does not return to baseline until after the contraction is over (Fig. 18-11).
FIG. 18-11 Late decelerations. (From Tucker, S. [2004]. Pocket guide to fetal monitoring and assessment [5th ed.]. St. Louis: Mosby.)
Uteroplacental insufficiency causes late decelerations. Persistent and repetitive late decelerations usually indicate the presence of fetal hypoxemia stemming from insufficient placental perfusion during UCs. If recurrent or sustained, late decelerations can lead to metabolic acidemia (Tucker et al., 2009). They should be considered an ominous sign when they are uncorrectable, especially if they are associated with absent or minimal variability and tachycardia. Several factors can disrupt oxygen transfer to the fetus, including maternal hypotension, uterine tachysystole (e.g., more than five contractions in 10 minutes, averaged over a 30-minute window), preeclampsia, postdate or postterm pregnancy, amnionitis, small-for-gestational-age fetuses, maternal diabetes, placenta previa, placental abruption, conduction anesthetics, maternal cardiac disease, and maternal anemia. The clinical significance and nursing interventions for late decelerations are described in Box 18-5.
Variable Decelerations: Variable deceleration of the FHR is defined as a visually abrupt (onset to lowest point less than 30 seconds) decrease in FHR below the baseline. The decrease is at least 15 beats/min or more below the baseline, lasts at least 15 seconds, and returns to baseline in less than 2 minutes from the time of onset (Macones et al., 2008). Variable decelerations occur any time during the uterine contraction phase and are caused by compression of the umbilical cord (Fig. 18-12).
FIG. 18-12 Variable decelerations. (From Tucker, S. [2004]. Pocket guide to fetal monitoring and assessment [5th ed.]. St. Louis: Mosby.)
The appearance of variable decelerations differs from those of early and late decelerations, which closely approximate the shape of the corresponding UC. Instead, variable decelerations have a U, V, or W shape, characterized by a rapid descent and ascent to and from the nadir (lowest point) of the deceleration (see Fig. 18-12). Some variable decelerations are preceded and
followed by brief accelerations of the FHR, known as “shoulders,” which is an appropriate compensatory response to compression of the umbilical cord.
Occasional variables have little clinical significance. Recurrent variable decelerations, however, indicate repetitive disruption in the fetus’s oxygen supply. This can result in hypoxemia and metabolic acidemia (Tucker et al., 2009). Variable decelerations are most commonly found during the transition phase of first stage labor or the second stage of labor as a result of umbilical cord compression and stretching during fetal descent (Garite, 2007). Box 18-6 lists causes, clinical significance, and nursing interventions for variable decelerations.
Prolonged Decelerations: A prolonged deceleration is a visually apparent decrease (may be either gradual or abrupt) in FHR of at least 15 beats/min below the baseline and lasting more than 2 minutes but less than 10 minutes. A deceleration lasting more than 10 minutes is considered a baseline change (Macones et al., 2008) (Fig. 18-13).
FIG. 18-13 Prolonged decelerations. (From Tucker, S., Miller, L., & Miller, D. [2009]. Mosby’s pocket guide to fetal monitoring: A multidisciplinary approach [6th ed.]. St. Louis: Mosby.)
Prolonged decelerations are caused by a disruption in the fetal oxygen supply. They usually begin as a reflex response to hypoxia. If the disruption continues, however, the fetal cardiac tissue itself will become hypoxic, resulting in direct myocardial depression of the FHR (Tucker et al., 2009). Prolonged decelerations may be caused by prolonged cord compression, profound uteroplacental insufficiency, or perhaps sustained head compression. The presence and degree of hypoxia present are thought to correlate with the depth and duration of the deceleration, how abruptly it returns to the baseline, how much variability is lost during the deceleration, and whether rebound tachycardia and loss of variability occur after the deceleration (Garite, 2007).
Significant stimuli that may result in prolonged decelerations are a prolapsed umbilical cord or other forms of prolonged cord compression, prolonged uterine tachysystole, hypotension after spinal or epidural anesthesia or analgesia, placental abruption, eclamptic seizure, and rapid fetal descent through the birth canal. Other more benign causes of prolonged decelerations include pelvic examination, application of a spiral electrode, and sustained maternal Valsalva maneuver (Garite, 2007).
Care of the woman receiving EFM in labor begins with evaluation of the EFM equipment. The nurse must ensure that the monitor is recording FHR and UA accurately and that the tracing is interpretable. If external monitoring is not adequate, changing to a fetal spiral electrode or IUPC may be necessary. A checklist for fetal monitoring equipment can be used to evaluate the equipment functions (Box 18-7).
After ensuring that the monitor is recording properly, the FHR and UA tracings are evaluated regularly throughout labor. Guidelines for Perinatal Care, published jointly by the American Academy of Pediatrics (AAP) and ACOG (2007), recommends that the FHR tracing be evaluated at least every 30 minutes during the first stage of labor and every 15 minutes during the second stage of labor in low risk women. If risk factors are present, then the FHR tracing should be evaluated more frequently: every 15 minutes in the first stage of labor and every 5 minutes in the second stage of labor.
Based on assessment findings the nurse identifies relevant nursing diagnoses and expected outcomes of care, implements appropriate interventions, and evaluates the care provided (see the Nursing Process box). Assessing FHR and UA patterns, implementing independent nursing interventions, documenting observations and actions according to the established standard of care, and reporting abnormal patterns to the primary care provider (e.g., physician, certified nurse-midwife) are the responsibilities of the nurse providing care to women in labor.
Nurses must evaluate many factors to determine whether an FHR pattern is normal (reassuring) or abnormal (nonreassuring) (see the Nursing Process box). Nurses evaluate these factors based on the presence of other obstetric complications, progress in labor, and use of analgesia or anesthesia. They also must consider the estimated time interval until birth. Interventions are therefore based on clinical judgment of a complex, integrated process (Simpson & James, 2005).
As previously mentioned, a three tier system of categorizing FHR tracings is recommended (see Box 18-1). Category I FHR tracings are normal and strongly predictive of normal fetal acid-base status at the time of observation. These tracings may be followed in a routine manner and do not require any specific action. Category II FHR tracings are indeterminate. This category includes all tracings that do not meet category I or category III criteria. Category II tracings require continued observation and evaluation. Category III FHR tracings are abnormal. Immediate evaluation and prompt intervention is required when these patterns are identified (Macones et al., 2008.).
The five essential components of the fetal heart rate tracing that must be evaluated regularly are baseline rate, baseline variability, accelerations, decelerations, and changes or trends over time. Whenever one of these five essential components is assessed as abnormal, corrective measures must immediately be taken (see the Nursing Process box). The purpose of these actions is to improve fetal oxygenation (Tucker et al., 2009). The term intrauterine resuscitation is sometimes used to refer to specific interventions initiated when an abnormal FHR pattern is noted. Basic corrective measures include providing supplemental oxygen, instituting maternal position changes, and increasing intravenous fluid administration. These interventions are implemented to improve uterine and intervillous space blood flow and increase maternal oxygenation and cardiac output (Simpson & James, 2005). Box 18-8 lists basic interventions to improve maternal and fetal oxygenation status.
Depending on the underlying cause of the abnormal FHR pattern, other interventions, such as correcting maternal hypotension, reducing uterine activity, and altering second stage pushing techniques, also may be instituted (Tucker et al., 2009). Box 18-8 lists interventions for these specific problems. Some of the items listed are not independent nursing interventions. Any medications administered, for example, must be authorized either through inclusion in a specific unit protocol or by a specific order. Some interventions are specific to the FHR pattern. (See Table 18-3 and Boxes 18-5 and 18-6 for nursing interventions for tachycardia, late decelerations, and variable decelerations.) Based on the FHR response to these interventions the primary health care provider decides whether additional interventions should be instituted or whether immediate vaginal or cesarean birth should be performed.
A major shortcoming of EFM is its high rate of false-positive results. Even the most abnormal patterns are poorly predictive of neonatal morbidity. Therefore, other methods of assessment have been developed to evaluate fetal status. Fetal scalp stimulation and vibroacoustic stimulation and umbilical cord acid-base determination are frequently performed assessments. However, fetal scalp blood sampling and fetal pulse oximetry are rarely performed in the United States. Amnioinfusion and tocolytic therapy are interventions often used in an attempt to improve abnormal FHR patterns.
Fetal Scalp Stimulation and Vibroacoustic Stimulation
Several research studies undertaken in the 1980s found that an FHR acceleration in response to digital or vibroacoustic stimulation was highly predictive of a normal scalp blood pH. The two methods of fetal stimulation used most often in clinical practice are scalp stimulation (using digital pressure during a vaginal examination) and vibroacoustic stimulation (using an artificial larynx or fetal acoustic stimulation device on the maternal abdomen over the fetal head for 1 to 5 seconds). The desired result of both methods of stimulation is an acceleration in the FHR of at least 15 beats/min for at least 15 seconds (Tucker et al., 2009). An FHR acceleration indicates the absence of metabolic acidemia. If the fetus does not respond to stimulation with an acceleration, fetal compromise is not necessarily indicated; however, further evaluation of fetal well-being is needed. Fetal stimulation should be performed at times when the FHR is at baseline. Neither fetal scalp stimulation nor vibroacoustic stimulation should be instituted if FHR decelerations or bradycardia is present (Tucker et al.).
In assessing the immediate condition of the newborn after birth, a sample of cord blood is a useful adjunct to the Apgar score. The procedure is generally performed by withdrawing blood from both the umbilical artery and the umbilical vein. Both samples are then tested for pH, carbon dioxide pressure (Pco2), oxygen pressure (Po2), and base deficit or base excess (Garite, 2007; Tucker et al., 2009). Umbilical arterial values reflect fetal condition, whereas umbilical vein values indicate placental function (Tucker et al.).
ACOG (2006a) suggests obtaining cord blood values in the following clinical situations: cesarean birth for fetal compromise, low 5-minute Apgar score, severe intrauterine growth restriction, abnormal FHR tracing, maternal thyroid disease, intrapartum fever, and multifetal gestation. Normal umbilical artery and vein cord blood values are listed in Table 18-4. Normal findings preclude the presence of acidemia at, or immediately before, birth. If acidemia is present (e.g., pH less than 7.20), then the type of acidemia is determined (respiratory, metabolic, or mixed) by analyzing the blood gas values (Table 18-5) (Tucker et al., 2009).
Sampling of the fetal scalp blood for pH determination was first described in the 1960s and performed extensively in the 1970s. The procedure is performed by obtaining a sample of fetal scalp blood through the dilated cervix after the membranes have ruptured. Its use is limited by many factors, including the requirement for cervical dilation and membrane rupture, technical difficulty of the procedure, need for repetitive pH determinations, and uncertainty regarding interpretation and application of results. This procedure is now seldom used in the United States but remains a common practice in other countries (Tucker et al., 2009).
Fetal pulse oximetry or continuous monitoring of fetal oxygen saturation levels is a fetal assessment that indirectly measures the oxygen saturation of hemoglobin in fetal blood. An intrauterine sensor placed in contact with the fetal cheek or temple area provides a continuous estimation of fetal oxygen saturation. Fetal pulse oximetry was approved for clinical use by the U.S. Food and Drug Administration in May 2000. The hope was that this technology would help to interpret abnormal (nonreassuring) FHR patterns more accurately and perhaps decrease the number of cesarean births performed for nonreassuring FHR tracings (Garite, 2007). Several studies, however, found that although fetal pulse oximetry did decrease the incidence of cesarean births for fetal indications, it had no consistent effect on overall cesarean birth rates or newborn outcomes. Therefore, fetal pulse oximetry has not proven to be a clinically useful test for determining fetal status (ACOG, 2009). Because the manufacturer no longer distributes the sensors, the product has in effect been taken off the market (Tucker et al., 2009).
Amnioinfusion is infusion of room-temperature isotonic fluid (usually normal saline or lactated Ringer’s solution) into the uterine cavity if the volume of amniotic fluid is low. Without the buffer of amniotic fluid the umbilical cord can easily become compressed during contractions or fetal movement, diminishing the flow of blood between the fetus and placenta. The purpose of amnioinfusion is to relieve intermittent umbilical cord compression that results in variable decelerations and transient fetal hypoxemia by restoring the amniotic fluid volume to a normal or near-normal level (Tucker et al., 2009). Women with an abnormally small amount of amniotic fluid (oligohydramnios) or no amniotic fluid (anhydramnios) are candidates for this procedure. Conditions that can result in oligohydramnios or anhydramnios are uteroplacental insufficiency and premature rupture of membranes.
In the past, amnioinfusion was also used to dilute moderate to thick meconium in an attempt to prevent meconium aspiration syndrome. However, a large research study found that amnioinfusion did not significantly reduce the incidence of meconium aspiration syndrome or perinatal death (Fraser, Hofmeyr, Lede, Faron, Alexander, Goffinet, et al., 2005). Therefore routine amnioinfusion for meconium-stained amniotic fluid without the presence of variable decelerations is not recommended by ACOG (2006b).
Risks of amnioinfusion are overdistention of the uterine cavity and increased uterine tone. Fluid is administered through an IUPC either by gravity flow or by an infusion pump. Usually a bolus of fluid is administered over 20 to 30 minutes, then the infusion is slowed to a maintenance rate. Likely no more than 1000 ml of fluid will need to be administered. The fluid may be warmed for the preterm fetus by infusing it through a blood warmer (Tucker et al., 2009).
Intensity and frequency of UCs should be continually assessed during the procedure. The recorded uterine resting tone during amnioinfusion will appear higher than normal because of resistance to outflow and turbulence at the end of the catheter. Uterine resting tone should not exceed 40 mm Hg during the procedure. The amount of fluid return must be estimated and documented during amnioinfusion to prevent overdistention of the uterus. The volume of fluid returned should be approximately the same as the amount infused (Tucker et al., 2009).
Tocolysis (relaxation of the uterus) can be achieved through the administration of drugs that inhibit UCs. This therapy can be used as an adjunct to other interventions in the management of fetal stress when the fetus is exhibiting abnormal patterns associated with increased UA. Tocolysis improves blood flow through the placenta by inhibiting UCs. Tocolysis may be implemented by the primary health care provider when other interventions to reduce UA, such as maternal position change and discontinuance of an oxytocin infusion, have no effect on diminishing the UCs. Tocolytics are often administered when women are having excessive UCs spontaneously. Tocolytics are also frequently administered after a decision for cesarean birth has been made while preparations for surgery are under way. The most commonly used tocolytic in these situations is terbutaline (Brethine), given subcutaneously. Terbutaline works quickly and has been demonstrated to improve Apgar scores and cord pH values without apparent complications (Garite, 2007). If the FHR and UC patterns improve, the woman may be allowed to continue labor; if no improvement is seen, immediate cesarean birth may be needed.
Although the use of EFM can be reassuring to many parents, it can be a source of anxiety to some. Therefore, the nurse must be particularly sensitive and respond appropriately to the emotional, informational, and comfort needs of the woman in labor and those of her family (Fig. 18-14 and Box 18-9).
FIG. 18-14 A nurse explains electronic fetal monitoring as ultrasound transducer monitors the fetal heart rate. (Courtesy Marjorie Pyle, RNC, Lifecircle, Costa Mesa, CA.)
Part of the nurse’s role includes acting as a partner with the woman to achieve a high-quality birthing experience. In addition to teaching and supporting the woman and her family with understanding of the laboring and birth process, breathing techniques, use of equipment, and pain management techniques, the nurse can assist with two factors that have an effect on fetal status: positioning and pushing. The nurse should solicit the woman’s cooperation in avoiding the supine position. Instead, the woman should be encouraged to maintain a side-lying position or semi-Fowler’s position with a lateral tilt to the uterus. In addition, the nurse should instruct the woman to keep her mouth and glottis open and to let air escape from her lungs during the pushing process. Both of these interventions will help to improve fetal oxygenation. See Chapter 19 for further discussion of maternal positioning and pushing techniques.
Clear and complete documentation in the woman’s medical record is essential. Each FHR and UA assessment must be completely documented in the woman’s medical record. More and more hospitals are moving to use of the electronic medical record and computerized charting. With computerized charting, each required component usually appears on the screen so that it will routinely be addressed. Computerized charting often includes forced choices that greatly increase the use of standardized FHR terminology by all members of the health care team. In the past, nurses were often encouraged to chart both on the monitor strip and in the medical record. However, charting directly on the monitor strip is unnecessary when an electronic medical record is used. Any information that is handwritten on the monitor strip will not be recorded in the computer record. Furthermore, given that the EFM tracing is stored on computer, the paper strips are destroyed after the woman is discharged. No permanent record of the handwritten charting exists.
In institutions that still use a paper chart, documentation on the woman’s monitor strip is started before the initiation of monitoring and consists of identifying information plus other relevant data. This documentation is continued and updated according to institutional protocol as monitoring progresses. See Box 18-10 for a checklist that can be used for documentation in a paper medical record. In some institutions, observations noted and interventions implemented are recorded on the monitor strip to produce a comprehensive document that chronicles the course of labor and the care rendered. In other institutions, this documentation is confined to the labor flow record. Advocates of documenting on both the medical record and the EFM strip cite as advantages of this approach the ease of writing directly on the strip while at the bedside and the improved accuracy in documenting critical events and the interventions implemented. Others believe that charting on the EFM strip constitutes duplicate documentation of the same information noted in the medical record, and thus it is unnecessary additional paperwork for the nurse.
A disadvantage of documenting on both the EFM strip and the medical record is that the times noted for events and interventions on the EFM strip frequently do not correlate with what is later documented in the medical record. These inaccuracies can lead persons involved in the retrospective review process carried out during litigation to infer that documentation errors have occurred. Therefore, if institutional policy mandates documentation both on the monitor strip and in the medical record, the nurse must make sure the times and notations of events and interventions recorded in each place agree. Many of the aspects of care and events that can be documented on the client’s medical record or the monitor strip are listed in Box 18-10.
KEY POINTS
• Fetal well-being during labor is gauged by the response of the FHR to UCs.
• Standardized definitions for many common FHR patterns have been adopted for use in clinical practice by ACNM, ACOG, and AWHONN.
• The five essential components of the fetal heart rate tracing are baseline rate, baseline variability, accelerations, decelerations, and changes or trends over time.
• The monitoring of fetal well-being includes FHR and UA assessment, as well as assessment of maternal vital signs.
• Assessing FHR and UA patterns, implementing independent nursing interventions, and reporting abnormal patterns to the physician or nurse-midwife are the nurse’s responsibilities.
• AWHONN and ACOG have established and published health care provider standards and guidelines for FHR monitoring.
• The emotional, informational, and comfort needs of the woman and her family must be addressed when the mother and her fetus are being monitored.
• Documentation of fetal assessment is initiated and updated according to institutional protocol.
Audio Chapter Summaries Access an audio summary of the Key Points on
Albers, L. The evidence for physiologic management of the active phase of the first stage of labor. Journal of Midwifery & Women’s Health. 2007;52(3):207–215.
American Academy of Pediatrics (AAP) and American College of Obstetricians and Gynecologists (ACOG). Guidelines for perinatal care, 6th ed. Washington, DC: ACOG; 2007.
American College of Obstetricians and Gynecologists (ACOG). Umbilical cord blood gas and acid-base analysis. ACOG Committee Opinion. Washington, DC: ACOG; 2006.
American College of Obstetricians and Gynecologists (ACOG). Amnioinfusion does not prevent meconium aspiration syndrome. ACOG Committee Opinion No. 346. Washington, DC: ACOG; 2006.
American College of Obstetricians and Gynecologists (ACOG). Intrapartum fetal heart rate monitoring: Nomenclature, interpretation, and general management principles. ACOG Practice Bulletin No. 106. Washington, DC: ACOG; 2009.
Association of Women’s Health, Obstetric and Neonatal Nurses. Fetal heart monitoring principles and practice, 4th ed. Dubuque, IA: Kendall/Hunt; 2009.
Cunningham, F., Leveno, K., Bloom, S., Hauth, J., Rouse, D., Spong, C. Williams obstetrics, 23rd ed. New York: McGraw-Hill; 2010.
Fraser, W., Hofmeyr, J., Lede, R., Faron, G., Alexander, S., Goffinet, F., et al. Amnioinfusion trial group: Amnioinfusion for the prevention of the meconium aspiration syndrome. New England Journal of Medicine. 2005;353(9):909–917.
Garite, T. Intrapartum fetal evaluation. In Gabbe S., Niebyl J., Simpson J., eds.: Obstetrics: Normal and problem pregnancies, 5th ed., Philadelphia: Churchill Livingstone, 2007.
Gilbert, E. Manual of high risk pregnancy & delivery, 5th ed. St. Louis: Mosby; 2011.
Hamilton, B., Martin, J., Ventura, S. Births: Preliminary data for 2008. National Vital Statistics Reports. 2010;58(16):1–18.
Macones, G., Hankins, G., Spong, C., Hauth, J., Moore, T. The 2008 National Institute of Child Health and Human Development Workshop Report on Electronic Fetal Monitoring: Update on definitions, interpretation, and research guidelines. Journal of Obstetric, Gynecologic and Neonatal Nursing. 2008;37(5):510–515.
Nageotte, M., Gilstrap, L. Intrapartum fetal surveillance. In Creasy R., Resnik R., Iams J., Lockwood C., Moore T., eds.: Creasy & Resnik’s maternal-fetal medicine: Principles and practice, 6th ed., Philadelphia: Saunders, 2009.
National Institute of Child Health and Human Development Research Planning Workshop. Electronic fetal heart rate monitoring: Research guidelines for interpretation. American Journal of Obstetrics and Gynecology. 1997;177(6):1385–1390.
Simpson, K., James, D. Efficacy of intrauterine resuscitation techniques in improving fetal oxygen status during labor. Obstetrics and Gynecology. 2005;105(6):1362–1368.
Tucker, S., Miller, L., Miller, D. Mosby’s pocket guide to fetal monitoring: A multidisciplinary approach, 6th ed. St. Louis: Mosby; 2009.